New Test for Evaluating Drug Sensitivity in Trichomonas vaginalis
Author Information
Author(s): Natalia Makhlay
Primary Institution: St.Petersburg Pasteur Institute
Hypothesis
The study aims to develop a reliable and standard test for evaluating the sensitivity of Trichomonas vaginalis to anti-trichomonas drugs.
Conclusion
The new test shows a high frequency of drug-resistant strains of Trichomonas vaginalis, highlighting the need for in vitro sensitivity testing for effective therapy selection.
Supporting Evidence
- The test identified varying levels of drug resistance among Trichomonas vaginalis strains.
- A total of 99 patients with chronic trichomoniasis were examined using the new test.
- The study found that many strains of Trichomonas vaginalis were resistant to commonly used drugs.
Takeaway
This study created a new test to see how well drugs work against a germ that causes an infection, and found many germs that don't respond to the usual medicine.
Methodology
The test involved using a nutrient medium, a special device for microscopic study, and an 8-well strip with drugs to determine minimal inhibitory concentrations.
Participant Demographics
Patients confirmed to have chronic trichomoniasis.
Want to read the original?
Access the complete publication on the publisher's website